During the past decade, Västerås Hospital conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 6 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 3 clinical trials were completed. i.e. 27.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Västerås Hospital" #1 sponsor was "Uppsala University" with 10 trials, followed by "Karolinska Institutet" with 6 trials sponsored, "Region Västmanland" with 4 trials sponsored, "Bayer" with 2 trials sponsored and "Lund University Hospital" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Västerås Hospital" #1 collaborator was "Uppsala University" with 4 trials as a collaborator, "Centrallasarettet Västerås" with 3 trials as a collaborator, "The Swedish Research Council" with 3 trials as a collaborator, "University Hospital, Linkoeping" with 3 trials as a collaborator and "Helsingborgs Hospital" with 2 trials as a collaborator. Other collaborators include 53 different institutions and companies that were collaborators in the rest 55 trials.

According to Clinical.Site data, the most researched conditions in "Västerås Hospital" are "Rectal Cancer" (3 trials), "Acute Myocardial Infarction" (2 trials), "Atrial Fibrillation" (2 trials), "Breast Cancer" (2 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Västerås Hospital" in a lesser frequency.

Most popular intervention types in "Västerås Hospital" are "Drug" (19 trials), "Procedure" (14 trials), "Other" (8 trials), "Device" (4 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "bococizumab (PF-04950615)" (2 trials), "100% oxygen" (1 trials), "30% oxygen" (1 trials) and ": A support program to facilitate implementation of evidence-based practice for postoperative urinary retention" (1 trials). Other intervention names were less common.

The vast majority of trials in "Västerås Hospital" are 41 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Västerås Hospital". undefined are not yet recruiting, 13 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Västerås Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Västerås Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 21 trials that are defined as “Not Applicable".